ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2015 American Transplant Congress

    Results from the Use of Aortohepatic Conduit in Orthotopic Liver Transplantation: A Single Centre 12-Year Experience

    M. Aly, N. Chatzizacharias, A. Gimson, E. Huguet, A. Butler, C. Watson, G. Pettigrew, A. Jah, N. Jamieson, R. Praseedom.

    Department of Surgery, Addenbrooke's Hospital, Cambridge, United Kingdom.

    Our study investigates the outcomes of the use of aortohepatic conduits in OLT.Methods: This is a retrospective single centre analysis of prospectively collected data from…
  • 2015 American Transplant Congress

    Risk of Post Liver Transplant (LT) Hepatocellular Carcinoma (HCC) Recurrence Is 2-Fold Higher in Women Compared to Men With AFP Levels at LT Between 101-500

    M. Sarkar,1 J. Dodge,2 F. Yao,1 J. Roberts,2 N. Terrault,1 N. Mehta.1

    1Medicine, University of California, San Francisco, San Francisco; 2Surgery, University of California, San Francisco, San Francisco.

    Gender differences in HCC incidence are known, with men at greater risk than women. Pre transplant AFP levels strongly predict post LT HCC recurrence, though…
  • 2015 American Transplant Congress

    Pediatric Liver Transplantation: An Outcome Analysis of a 30-Year Single Center Experience

    A. Weissenbacher,1 C. Margreiter,1 R. Oberhuber,1 M. Maglione,1 B. Cardini,1 J. Grahammer,1 T. Müller,2 R. Margreiter,1 S. Schneeberger.1

    1Department for Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria; 2Department of Paediatrics I, Innsbruck Medical University, Innsbruck, Austria.

    Introduction: In this study we aim to assess factors influencing long-term patient and graft survival as well as surgical parameters and risk factors influencing organ…
  • 2015 American Transplant Congress

    Is Transplant Volume Associated With Survival in Pediatric Liver Transplants?

    W. Cherikh,1 H. Kim,2 A. Wilk,1 C. Flavin,1 E. Brewer.3

    1United Network for Organ Sharing, Richmond, VA; 2Boston Children's Hospital, Boston, MA; 3Baylor Coll Med & Texas Children's Hosp, Houston, TX.

    Background. Center specific volume has been shown to correlate with outcomes for many procedures in the adult population. The current study was conducted to determine…
  • 2015 American Transplant Congress

    Hepatocyte-Related miR-193a-3p Is Over-Expressed in Allograft Biopsy from Liver Tolerant Recipients

    R. Danger, J. Lozano, E. Bonaccorsi-Riani, E. Kodela, R. Mas-Malavila, M.-C. Londono, M. Martinez, A. Rimola, M. Martinez-Llordella, A. Sanchez-Fueyo.

    Department of Liver Sciences, Faculty of Life Sciences & Medicine, MRC Transplant Centre, King's College London, London, United Kingdom; Liver Unit and Bioinformatic Platform, IDIBAPS, University of Barcelona and Hospital Clinic Barcelona, Barcelona, Spain.

    While liver transplantation is the treatment of choice for end-stage liver diseases, its success is compromised by the need to administer life-long immunosuppression, which negatively…
  • 2015 American Transplant Congress

    Use of Tissue Plasminogen Activator (TPA) in Liver Transplantation from Donation After Cardiac Death (DCD) Donors: A Controlled Randomized Trial

    B. Eghtesad, K. Hashimoto, M. Watson, M. Nazzal, C. Quintini, D. Kelly, T. Diago, N. Kawamura, G. El-Gazzaz, M. Fujiki, F. Aucejo, C. Winans, C. Miller, J. Fung.

    Hepatobiliary and Liver Transplant Surgery, Cleveland Clinic, Cleveland, OH.

    To further evaluate the impact of tPA in reduction of ITBS in livers recovered from the DCD donors we conducted a controlled randomized trial. Between…
  • 2015 American Transplant Congress

    Living Donor Liver Transplantation for Biliary Atresia has Equivalent Survival and Shorter Waiting Time Compared to Deceased Donor Liver Transplantation

    S. Alexopoulos,1 V. Nekrasov,1 L. Matsuoka,1 K. Chouliaras,2 Y. Genyk.1

    1Department of Surgery, Keck Medical Center of USC, Los Angeles, CA; 2Department of Surgery, Wake Forest University, Winston-Salem, NC.

    Purpose: To determine the benefit of living donor liver transplantation (LDLT) compared to deceased donor liver transplantation (DDLT) in the treatment of end stage liver…
  • 2015 American Transplant Congress

    Efficacy of Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation

    A. Weick,1 K. George,1 S.-M. Jafri,2 D. Moonka.2

    1Internal Medicine, Henry Ford Hospital, Detroit, MI; 2Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI.

    Purpose: Evaluate outcomes of sofosbuvir-based hepatitis C therapy in liver transplant patients in a single center clinical setting, including interferon-free regimens.Methods: All patients with history…
  • 2015 American Transplant Congress

    Pharmacist-Led Renal-Sparing Conversion to Everolimus After Liver Transplantation

    T. Horwedel,1 L. Bowman,1 W. Chapman,2 J. Hagopian.1

    1Barnes-Jewish Hospital, St. Louis, MO; 2Washington University in St. Louis, St. Louis, MO.

    Purpose: Preservation of renal function following orthotopic liver transplantation (OLT) through calcineurin inhibitor (CNI)-minimization is an established clinical objective. The use of everolimus (EVR) to…
  • 2015 American Transplant Congress

    Predicting Renal Recovery After Liver Transplant With Severe Pretransplant Sub-Acute Kidney Injury: The Impact of Warm Ischemic Time

    H. Laskey, T. Nydam, A. Wiseman, S. Biggins.

    Hepatology, Transplant Surgery and Nephrology, Univ. Colorado, Aurora, CO.

    Identification of which liver transplant candidates with severe kidney injury can have full recovery of renal function after liver only transplant is difficult. Avoiding unnecessary…
  • « Previous Page
  • 1
  • …
  • 163
  • 164
  • 165
  • 166
  • 167
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences